Boston Scientific Corporation  

(Public, NYSE:BSX)   Watch this stock  
Find more results for Boston Scientific Corporation�
13.65
+0.15 (1.11%)
Apr 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 13.43 - 13.71
52 week 7.07 - 14.08
Open 13.48
Vol / Avg. 8.68M/12.09M
Mkt cap 18.07B
P/E     -
Div/yield     -
EPS -0.09
Shares 1.32B
Beta 1.07
Inst. own 90%
May 8, 2014
Boston Scientific Corporation Investor Event - 8:00PM EDT - Add to calendar
May 6, 2014
Boston Scientific Corporation Annual Shareholder Meeting - 11:00AM EDT - Add to calendar
Apr 29, 2014
Q1 2014 Boston Scientific Corporation Earnings Release - 9:30AM EDT - Add to calendar
Apr 29, 2014
Q1 2014 Boston Scientific Corporation Earnings Conference Call - 8:00AM EDT - Add to calendar
Mar 11, 2014
Boston Scientific Corporation at Barclays Healthcare Conference - Q&A Session - Webcast
Mar 11, 2014
Boston Scientific Corporation at Barclays Healthcare Conference - Webcast
Mar 4, 2014
Boston Scientific Corporation at Cowen Health Care Conference - Webcast
Feb 26, 2014
Boston Scientific Corporation at RBC Capital Markets Healthcare Conference - Webcast
Feb 26, 2014
Boston Scientific Corporation at Citi Global Healthcare Conference - Webcast
Feb 12, 2014
Boston Scientific Corporation at Leerink Swann Global Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 5.88% -1.69%
Operating margin 6.86% 1.68%
EBITD margin - 22.34%
Return on average assets 2.59% -0.72%
Return on average equity 6.61% -1.80%
Employees 23,000 -
CDP Score - 44

Address

ONE BOSTON SCIENTIFIC PL
NATICK, MA 01760-1537
United States - Map
+1-508-6508000 (Phone)
+1-508-6508923 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women�s Health, Neuromodulation, and Electrophysiology. In January 2011, it completed the acquisition of Intelect Medical, Inc. In June 2012, the Company acquired Cameron Health, Inc. of San Clemente, California and, as a result, added to its product portfolio subcutaneous implantable cardioverter defibrillator, called the S-ICD System. In November 2013, the Company announced that it has acquired Bard EP, the electrophysiology (EP) business of C.R. Bard, Inc. In February 2014, Boston Scientific Corp acquired StarMedTec GmbH, a Starnberg-based manufacturer of medical laser systems.

Officers and directors

Peter M. Nicholas Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael F. Mahoney President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Daniel Brennan Chief Financial Officer, Executive Vice President
Age: 48
Bio & Compensation  - Reuters
Timothy A. Pratt Chief Administrative Officer, Executive Vice President, General Counsel, Secretary
Age: 63
Bio & Compensation  - Reuters
Supratim Bose Executive Vice President and President, Asia-Pacific
Age: 60
Bio & Compensation  - Reuters
Keith D. Dawkins M.D. Global Chief Medical Officer, Executive Vice President
Age: 62
Bio & Compensation  - Reuters
Michael P. Phalen Executive Vice President and President - MedSurg
Age: 53
Bio & Compensation  - Reuters
Kenneth J. Pucel Executive Vice President - Global Operations, Quality and Technology
Age: 46
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jean Fitterer Lance Chief Compliance Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Wendy Carruthers Senior Vice President - Human Resources
Age: 44
Bio & Compensation  - Reuters